Jill Shwed McCollam

Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)

Ohsang Kwon, Maryanne M. Senna, Rodney Sinclair et al. · American Journal of Clinical Dermatology · 2023 · 147 citations · Full text

Medicine, Dermatology, Pharmacology +13

Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study

Brett King, Justin Ko, Seth Forman et al. · Journal of the American Academy of Dermatology · 2021 · 114 citations · Full text

Medicine, Dermatology, Pharmacology +13

Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis

Philip S. Barie, Mark D. Williams, Jill Shwed McCollam et al. · The American Journal of Surgery · 2004 · 109 citations

Veterinary Medicine, Pharmacotherapy, Surgery +17

Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia

Christopher M. Rubino, Scott A. Van Wart, Sujata M. Bhavnani et al. · Antimicrobial Agents and Chemotherapy · 2009 · 82 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: A prospective, randomized comparison

Jill Shwed McCollam, Michael G. O’Neil, E. Douglas Norcross et al. · Critical Care Medicine · 1999 · 80 citations

Medicine, Anesthesiology, Surgery +17